In last trading session, Alaunos Therapeutics Inc (NASDAQ:TCRT) saw 13.63 million shares changing hands with its beta currently measuring -1.01. Company’s recent per share price level of $2.80 trading at $0.64 or 29.63% at ring of the bell on the day assigns it a market valuation of $4.49M. That closing price of TCRT’s stock is at a discount of -560.71% from its 52-week high price of $18.50 and is indicating a premium of 53.21% from its 52-week low price of $1.31. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.92 million shares which gives us an average trading volume of 102.00K if we extend that period to 3-months.
For Alaunos Therapeutics Inc (TCRT), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Alaunos Therapeutics Inc (NASDAQ:TCRT) trade information
Upright in the green during last session for gaining 29.63%, in the last five days TCRT remained trading in the green while hitting it’s week-highest on Wednesday, 04/02/25 when the stock touched $2.80 price level, adding 12.77% to its value on the day. Alaunos Therapeutics Inc’s shares saw a change of 46.98% in year-to-date performance and have moved 83.01% in past 5-day. Alaunos Therapeutics Inc (NASDAQ:TCRT) showed a performance of 87.92% in past 30-days. Number of shares sold short was 51732.0 shares which calculate 5.18 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 51.16% during past 5 years.
Alaunos Therapeutics Inc (NASDAQ:TCRT)’s Major holders
Insiders are in possession of 14.11% of company’s total shares while institution are holding 4.51 percent of that, with stock having share float percentage of 5.25%. Investors also watch the number of corporate investors in a company very closely, which is 4.51% institutions for Alaunos Therapeutics Inc that are currently holding shares of the company. MSD PARTNERS, L.P. is the top institutional holder at TCRT for having 1.01 million shares of worth $0.71 million. And as of 2024-06-30, it was holding 6.3082 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 0.22 million shares on 2024-06-30. The number of shares represents firm’s hold over 1.3892 of outstanding shares, having a total worth of $0.16 million.
